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Abstract – West Nile virus (WNV) is a ﬂavivirus (Flaviviridae) transmitted between Culex spp.
mosquitoes and avian hosts. The virus has dramatically expanded its geographic range in the past ten years.
Increases in global commerce, climate change, ecological factors and the emergence of novel viral
genotypes likely play signiﬁcant roles in the emergence of this virus; however, the exact mechanism and
relative importance of each is uncertain. Previously WNV was primarily associated with febrile illness of
children in endemic areas, but it was identiﬁed as a cause of neurological disease in humans in 1994. This
modulation in disease presentation could be the result of the emergence of a more virulent genotype as well
as the progression of the virus into areas in which the age structure of immunologically naı ¨ve individuals
makes them more susceptible to severe neurological disease. Since its introduction to North America in
1999, a novel WNV genotype has been identiﬁed that has been demonstrated to disseminate more rapidly
and with greater efﬁciency at elevated temperatures than the originally introduced strain, indicating the
potential importance of temperature as a selective criteria for the emergence of WNV genotypes with
increased vectorial capacity. Even prior to the North American introduction, a mutation associated with
increased replication in avian hosts, identiﬁed to be under adaptive evolutionary pressure, has been
identiﬁed, indicating that adaptation for increased replication within vertebrate hosts could play a role in
increased transmission efﬁciency. Although stable in its evolutionary structure, WNV has demonstrated the
capacity for rapidly adapting to both vertebrate hosts and invertebrate vectors and will likely continue to
exploit novel ecological niches as it adapts to novel transmission foci.
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The purpose of this review is to present
some of the potential factors that have been
associated with the emergence of West Nile
virus (WNV) from an endemic virus, generally
associated with childhood disease, to an agent
that has rapidly expanded its geographic range,
becoming established in the New World with
novel, more serious disease manifestations.
Ecological, virological, epidemiological and
entomological avenues are explored to address
this phenomenon.
1.1. Viral classiﬁcation
West Nile virus is a member of the genus
Flavivirus within the family Flaviviridae [59]
and was ﬁrst isolated from a human experienc-
ing a febrile syndrome in the West Nile district
of Uganda in 1937 [142]. Serological cross
reactivity has grouped WNV within the Japa-
nese encephalitis (JE) virus serocomplex [27].
In addition to WNV, the JE serocomplex
includes three other viral species respon-
sible for human disease including Japanese
encephalitis (JEV), St. Louis encephalitis
(SLEV) and Murray Valley encephalitis
(MVEV) viruses [94].
Despite the name ‘‘serocomplex’’, classiﬁca-
tion of these viruses is based on a combination
of serological cross reactivity, nucleotide
sequence data, and vector association [59].
The WNV species contains one viral subtype
(Kunjin), comprised of isolates from Australia
and Malaysia [157]. West Nile viruses have a
pandemic distribution having been isolated on
every continent with the exception of Antarctica
[57]. Despite the fact that serological assays dis-
tinguish WNV isolates from India as well as
Kunjin from other WNV, only Kunjin is classi-
ﬁed as a distinct viral subtype [156]. Nucleotide
sequence data has subsequently demonstrated
Kunjin viruses to have a greater genetic identity
with newly emergent WNV genotypes than Old
World strains including those from India [115,
135]. Altered serological reactivity is most
likely due to the lack of an additional glycosyl-
ation motif within the envelope glycoprotein of
Kunjin viruses [1].
1.2. Structure and replication
West Nile virus is comprised of an envel-
oped spherical virion with a diameter of
approximately 50 nm. The virus has a linear,
single-stranded, message-sense genome of
approximately 11 Kb with a 50(7-methyguano-
sine) cap and no polyadenylation at the 30end
of the genome [129]. The 50 and 30 non-coding
regions (NCR) have conserved nucleotide ele-
ments that form stem-loop structures necessary
for viral RNA transcription, translation and
packaging [25, 72, 139]. Viral proteins are
translated as a single polyprotein that is post-
translationally cleaved by host and viral prote-
ases to produce 3 structural (C, prM and E)
and 7 nonstructural proteins (NS1, NS2A,
NS2B, NS3, NS4A, NS4B and NS5). The 50
third of the genome encodes the structural
2. Factors associated with West Nile viral emergence............................................................................. 6
2.1. Virological factors associated with emergence........................................................................... 6
2.1.1. Emergence of avian virulence......................................................................................... 6
2.1.2. Genotype associated with avian virulence...................................................................... 7
2.1.3. Increased virulence as a factor for increased transmission............................................. 8
2.1.4. Viral adaptation for replication at higher temperature.................................................... 9
2.2. Environmental factors associated with emergence...................................................................... 10
2.2.1. Climate perturbation........................................................................................................ 10
2.2.2. Species diversity, species behavior and transmission dynamics..................................... 10
2.2.3. Role of heterologous flaviviruses on WNV transmission.............................................. 11
2.2.4. Alternation of transmission patterns................................................................................ 11
3. Conclusion ............................................................................................................................................ 12
Vet. Res. (2009) 40:43 A.C. Brault
Page 2 of 19 (page number not for citation purpose)proteins necessary for encapsidation of the viral
RNA and the surface proteins required for viral
receptor interaction and fusion with host cells
(Fig. 1) [76]. The remainder of the genome
encodes the nonstructural proteins that form
the viral replication complex for the generation
of negative-sense template RNA as well as
positive-sense genomic RNA [161]. The largest
of the NS proteins, NS3 and NS5, have been
characterized for interactions and replicase
activity; however, the function of the remaining
NS proteins is largely unknown. The NS5
protein has both RNA polymerase and methyl-
transferase motifs necessary for viral replica-
tion. Helicase and serine protease domains
have been described for the NS3 protein
[129]. Interestingly, the NS1 protein is a secre-
tory nonstructural protein that does not have a
designated function in RNA replication or as
a control element [162].
1.3. Molecular epidemiology of WNV
Phylogenetic trees based on nucleotide
sequence data indicate the existence of ﬁve
potentially distinct genetic lineages of WNV
that have diverged by up to 29% at the nucleo-
tide level [18, 89]. Sequence analysis of viral
strains from North America, Africa, the Middle
East, Asia, and Australia (Kunjin) constitute
lineage 1 based on structural [18, 63, 89] or
nonstructural gene regions [14, 29]. Phyloge-
netic analyses clearly indicate that Kunjin is a
member of lineage 1 and that the second line-
age WNV, restricted to a sub-Saharan African
distribution, are more distantly related to other
lineage 1 WNV than to Kunjin virus [135].
Lineage 3 WNV is represented by a Czech
Republic mosquito isolate (Rabensburg; RabV)
[11], lineage 4 is comprised of Dermacentor
spp. tick isolates from the Russian Caucasus
[117], and lineage 5 is represented by a separate
genotype from India [21]. Phylogenetic group-
ing of isolates does not correlate with geo-
graphic distribution, indicating the potential
importance of birds in viral dispersal [18].
All of the major outbreaks of human enceph-
alitis have been associated with viruses geneti-
cally categorized as lineage 1, making an
important correlation between viral genetics
and disease phenotype. The preponderance of
genetic evidence suggests that the introduction
of WNV into North America occurred from
the Middle East. Complete genomic sequencing
of an isolate from an outbreak in geese in Israel
in 1998 and NY99 strains of WNV group them
in the same genetic clade with a 99.7% shared
nucleotide identity [29, 90]. The identiﬁcation
of bird carcasses found to be positive for
WNV from a number of species in Israel pro-
vides evidence that naturally occurring bird vir-
ulent strains could be circulating within the
Middle East and were introduced into North
America [95].
1.4. Disease and distribution
Clinical disease in humans ranges from mild
fever to the development of severe neurological
disease[143];however,retrospectiveserological
studies have indicated that the majority of WNV
infections are actually asymptomatic [6, 154].
West Nile fever is the most common clinical
manifestation and is characterized by the devel-
opment of high fever, chills, rash, headache,
myalgia and nausea. Symptoms typically abate
within 3–5 days of onset and result in lifetime
immunity. WNV infection also may result in
Figure 1. Genomic organization of the WNV genome. Three structural proteins (C, prM, E) and seven
nonstructural proteins (NS1, 2A, 2B, 3, 4A, 4B and 5) are translated as a single polyprotein directly from
the 11 Kb positive-sense RNA genome.
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toms that include encephalitis, meningitis, mye-
litisorcombinationsofthesesymptoms[58,98].
Acute ﬂaccid paralysis of the limbs and respira-
tory muscles has been described in North Amer-
ica [8] and Romania [28].
Elderly individuals are at a greater risk for
developing severe neurological disease, with
younger patients more commonly developing
WN fever [106]. It is not readily clear whether
the more severe neurological symptoms are the
result of increased virulence of the introduced
strain or a reﬂection on the immunologically
naı ¨ve status of the population whose age struc-
ture might be more predisposed to severe dis-
ease manifestations. Postulated mechanisms of
viral entry to the CNS and subsequent develop-
ment of more severe disease include impaired
structural elements of the blood-brain barrier
(BBB) or impaired immunity with increased
age [143]; however, data generated with micro-
vascular endothelial cells indicates the mainte-
nance of BBB integrity following infection
with WNV, indicating the potential of free virus
to pass this barrier. Furthermore, increased cell
adhesion molecule expression observed in this
study indicated the potential for infected
immune cells to also traverse the BBB [158].
West Nile virus has been found to be ende-
mic to Europe [80], Africa [45, 101], Asia
and Australasia [69]. Within its geographic
range, outbreaks of febrile disease in humans
have occurred sporadically with well docu-
mented outbreaks being reported in Egypt
[149], France [64] and South Africa [68] with
outbreaks occurring in 2008 in Romania
[116], Hungary [84] and Italy [93, 133]. Like
in the USA [4, 5, 7], recent disease outbreaks
occurring in Romania [154], Italy [10, 104],
Russia [92] and Israel [30] have been associated
with the severe disease symptomology. Since its
introduction to the USA in 1999, a total of
28 975 human cases including 1 124 deaths
(through 2008) have been documented
(www.cdc.gov).
West Nile virus has demonstrated a wide
host range, infecting, for example, equines, alli-
gators [62], dogs [9], sheep [71], llamas [86],
alpacas [35, 87]; however, few animals consis-
tently demonstrate overt disease. The attack rate
for equines is approximately 5% with an esti-
mated 1 in 3 horses that demonstrate encephali-
tis succumbing to the disease [10, 26]. Other
than birds, some squirrel [51, 60, 78, 111,
113], chipmunk [112] and rabbit species
[153], and potentially alligators [79] most serve
as dead-end hosts in which circulating viremias
are not sufﬁcient for infection of mosquito
vectors.
1.5. Transmission of WNV
Since its identiﬁcation in 1937 from the
West Nile district in Uganda [142], WNV trans-
mission cycles have been extensively described
in Egypt [149], South Africa [68], Israel [109]
and Pakistan [3, 55, 121]. These maintenance
cycles have all included ornithophilic mosquito
species and mostly passerine avian hosts
(Fig. 2) that maintain sufﬁcient viremias for
the infection of subsequent mosquitoes. Isola-
tions have been made most extensively from
mosquitoes of the genus Culex, not only in
Egypt [148] but also throughout its pandemic
distribution [121]. In South Africa, although
isolations have been made from a wide range
of mosquitoes, Culex univittatus is the only
mosquito vector that is efﬁciently infected at
titers that are present in birds infected with
WNV. The role of alternative mosquito popula-
tions in viral transmission is presumably quite
low [66, 67]. In endemic transmission foci of
Australia, Culex annulirostris is the major mos-
quito vector [53], while the Culex vishnui com-
plex and Culex tritaeniorhynchus have been
implicated with transmission in India and
Pakistan [3, 102]. Evidence of seroconversions
of birds in endemic foci [81, 100, 165] and vire-
mia [164] and antibody [22] production follow-
ing experimental inoculation of bird species has
incriminated avian hosts as the vertebrate reser-
voir for WNV throughout its distribution. Addi-
tionally, certain mammalian species have been
found to, in some cases, develop sufﬁcient vire-
mia for infection of mosquito vectors [112, 113,
132]; however, the role that these hosts play in
the transmission dynamics of WNV are cur-
rently uncertain but of signiﬁcant interest due
to the potential infection of mammalophagic
mosquito vectors.
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logical ﬁnding for WNV transmission in Israel
[19] and North America [131], having never
before been reported during outbreaks of WN
fever in Europe [134] the Middle East [105]
or with endemic transmission in Australia [53]
or South Africa [68] (Fig. 2). In contrast
to Old World transmission, isolations of WNV
have been made from numerous species of
North American mosquitoes representing 11
genera. Mosquitoes most commonly infected
in the eastern USA have been members of the
Culex pipiens species complex, and this species
complex was also associated with
transmission during a human urban epidemic
in Romania in 1996 [154]. However, isolations
have been made from marginally competent
vectors such as the catholic vectors Aedes albo-
pictus and Aedes vexans [155].
In North America, West Nile virus rapidly
expanded its geographic range from four states
in 1999 to all contiguous 48 and Canada by
2004 [120]. With this westward transition,
WNV has adopted Culex tarsalis as its predom-
inant rural vector in western North America.
The mechanism for viral dispersal has not been
experimentally addressed; however, the extre-
mely high viremia titers present within both res-
ident and migratory bird species (> 150)
indicate the probable role of some of these bird
Figure2. Transmission cycles of WNV. Transmission occurs between ornithophilic mosquito species (Culex
spp.) and passeriform avian hosts. Birds typically manifest high viremias capable of exceeding oral infection
thresholds for many mosquito vectors. Humans and equines fail to generate sufﬁcient viremia for the
infection of mosquito hosts and are deemed ‘‘dead end’’ or tangential hosts. Red: Avian mortality was ﬁrst
identiﬁed in a migratory stork and subsequently in commercially farmed geese in the late 1990s and has
subsequently been associated with widespread mortality among numerous North American avian species (in
particular, corvids). (A color version of this ﬁgure is available at www.vetres.org.)
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tial for limited local dispersal by mosquitoes
[118].
1.6. Use of crow mortality to track
WNV activity
Deaths in American crow (AMCR) were
especially prevalent in New York City in
1999 [4] and monitoring of crow mortality
has been adopted as an epidemiological indica-
tor for the tracking of WNV transmission in the
USA and has proven useful in predicting
increased risk for human infections [39, 40,
65]. Dead crows with conﬁrmed WNV infec-
tions preceded the ﬁrst human cases by three
months in New York in 2000. Despite this fact,
there is no knowledge regarding the genetic
and/or pathological mechanism(s) of suscepti-
bility for WNV in crows or any other bird
species.
1.7. Virulence and immunity studies with WNV
West Nile virus neurovirulence has been
studied in primate [114] as well as mouse [13,
52, 160] and hamster models [166]. Age-related
resistance to neuroinvasion is typical of mos-
quito-borne ﬂaviviruses [42, 48]; however,
intraperitoneal infection of 15–16 week-old
mice and adult hamsters with the newly intro-
duced North American genotype induces fatal
encephalitis [13]. This ﬁnding is in contrast to
a study in which WNV encephalitis was rare
in mice older than 7 weeks of age following
inoculation with a WNV strain from Egypt
[160]. Genetic mapping studies have indicated
the importance of the IFN-inducible 20-50-oli-
goadenylate synthetase genes with resistance
to WNV infection [99].
Development of encephalitis is identiﬁed at
or near the time of clearance of virus from the
peripheral circulation concurrent with the pro-
duction of neutralizing antibody in a hamster
model of WNV encephalitis. This model has
also demonstrated that hematogenous spread
of the virus across the blood-brain barrier is
the most likely route of entry to the brain as
the olfactory ganglia were not reported to have
become infected [166]. Intranasal inoculation is
a highly inefﬁcient mode of inducing neurovi-
rulence in mice, further indicating that infection
of the olfactory bulb is likely not the most efﬁ-
cient mechanism of viral entry to the brain [13,
52, 110]. Inoculation of mice with different
WNV strains has demonstrated a correlation
between viral genotype and neurotropism
[13]; however, genotypes with increased neu-
rotropism do not correlate with increased bind-
ing to either human or mouse brain receptor
preparations [12, 107]. Unlike AMCR that have
generated titers of up to 10 log10 PFU/mL
serum and uniformly succumb to infection
within 5 days of infection [83], hamsters
have peak viremias of approximately 5 log10
TCID50/mL of serum, have approximately
50% survival rates and typically die 7–14 days
after infection with the NY99 WNV genotype
[166]. Antibody development may play an
important role in protecting hamsters from
potentially fatal encephalitis, since peripheral
viral titers dissipate as circulating neutralizing
antibody is produced [151, 166]. Immunization
of hamsters with heterologous ﬂaviviruses such
as Japanese encephalitis and St. Louis encepha-
litis viruses has demonstrated a protective effect
against lethal encephalitis [152]. Administration
of anti-ﬂaviviral antibodies within 4–6 days
post-infection has also been demonstrated to
be efﬁcacious for preventing ﬂaviviral encepha-
litis in a mouse model [130]. This time frame
correlates with viral invasion of neural tissues
[52, 130, 166]. Intraperitoneal inoculation of
WNV in a hamster model also demonstrates
that serum neutralizing antibody development
within ﬁve days of inoculation correlates with
decreased peripheral viral circulation [166].
2. FACTORS ASSOCIATED WITH
WEST NILE VIRAL EMERGENCE
2.1. Virological factors associated
with emergence
2.1.1. Emergence of avian virulence
An Egyptian strain, Ar-248, was isolated
f r o mam o r i b u n dp i g e o n( Columba livia) squab
in a ﬁeld study conducted from 1952-1954.
Vet. Res. (2009) 40:43 A.C. Brault
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experimentally infected hooded crows (Corvus
corone)a n dh o u s es p a r r o w s( Passer domesti-
cus) [164]. High seroprevalence rates within
hooded crow populations in Egypt coupled with
the rapid deaths of the experimentally inocu-
lated bird (some within 1 to 2 days of infec-
tion), indicate the possibility that mortality
could have been the result of experimental
handling of the birds rather than natural viru-
lence from infection [149].
No reports of natural WNV-associated mor-
tality in adult birds occurred during the ﬁrst six
decades since the discovery of the virus in 1937
[57]. However, signiﬁcant avian morbidity and
mortality have been recent hallmarks of WNV
outbreaks in Israel [19, 147] and North America
[17]. In 1998, WNV was identiﬁed in tissues
taken from dead migratory storks in Israel
[97] and later that year, an outbreak within
goose farms across Israel was identiﬁed.
Affected ﬂocks had severe mortality rates in
goslings between 3 and 8 weeks of age [96].
Experimental infection of goslings with viruses
later isolated from North America demonstrated
similar mortality and resulted in viremias that
were sufﬁcient to infect mosquito vectors
[147]. Evaluation of the virulence of WNV iso-
lated from New York in 1999 demonstrated
mortality in 8 of 25 species experimentally
infected. The most susceptible species were
the blue jay (Cyanocitta cristata), common
grackle (Quiscalus quiscula), house ﬁnch
(Carpodacus mexicanus), AMCR (Corvus
brachyrhynchos), and house sparrow (Passer
domesticus). Corvids (including AMCR, blue
jays andmagpies) all developedcirculating vire-
mias in excess of 8 log10 PFU/mL blood and in
some cases exceeded 10 log10 PFU/mL blood
[83]. Necropsy tissues taken from naturally
[145] and experimentally infected [83] AMCR
have demonstrated that the North American
WNV is not limited to infection of particular
organ systems, with virus being identiﬁed in
the brain, heart, kidney, lungs, gonads, spleen,
liver, intestines, esophagus and skin.
High mortality rates in AMCR and the quan-
tity of virus identiﬁed in various organs have
been factors for the adoption of crow mortality
as a surveillance tool to identify areas with
recent WNV activity [39, 40]. WNV infection
with the NY99 genotype has been identiﬁed
in more than 150 species of birds representing
over 20 bird families in North America, causing
morbidity in some cases but not necessarily
mortality [82, 83, 136]. Chickens, for example,
demonstrate no mortality following infec-
tion with WNV, yet titers as high as 5 log10
PFU/mL of serum have been identiﬁed and
virus can be isolated from myocardium, spleen,
kidney, lung, and intestine. Additionally, histo-
pathological examination has identiﬁed myo-
cardial necrosis, nephritis, and pneumonitis
most notably in young birds [136].
The genetic changes observed in different
WNV strains can modulate their virulence
potential in avian species [23, 91]. Kunjin
viruses have demonstrated low peak viremia
thresholds compared to alternative lineage 1
WNV strains in both AMCR [23] and HOSP
[91]. Other lineage 1 WNV, closely related to
but different from the highly avian virulent
NY99 WNV strain, have also demonstrated
reduced viremia and subsequently lowered
mortality rates in AMCR following experimen-
tal infection [77]. These data in accordance with
the ﬁnding that WNV strains circulating in
Israel that are genetically most similar to the
NY99 strain have been associated with avian
virulence [19] indicate that viral genetics play
a crucial role in host susceptibility to lethal
infection.
2.1.2. Genotype associated with avian virulence
Positive selection modeling of WNV repre-
sentingmembersofallofthelineageshasidenti-
ﬁed a single genetic loci (NS3-249) to be under
adaptive evolution [24]. This residue lies within
thehelicasedomainoftheNS3proteininanarea
notassociateddirectlywithRNAbindingorATP
hydrolysis; however, incorporation of a NY99
substitution (NS3-T249P) into a closely related
lineage 1 WNV that elicited a low level of viru-
lence in AMCR was sufﬁcient to elicit a viremia
and mortality response in crows indistin-
guishable from the NY99 strain. Interestingly,
this avian virulence mutation, NS3-249P, has
emerged on at least three independent occasions
(Fig. 3). In each case, the viruses with this
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ease outbreaks; however, only the Egyptian 1951
isolate [164] as well as viruses from the Israeli/
NorthAmericanclades[89]havebeenassociated
withavian virulence.The preponderance ofthese
data indicated the potential importance of avian
viremia for the emergence of lineage I WNV
and suggests the potential for the emergence of
alternative WNV genotypes following small
genetic changes. Interestingly, several WNV
lineages contain the NS3-249P substitution but
have not been associated with avian virulence or
the emergence of disease outbreaks indicating
the possible limitations that particular WNV
genetic backbones could impose on emergence
potential of alternative genotypes as well as the
potential role of the NS3-249P for increased rep-
lication in a wider array of avian species.
2.1.3. Increased virulence as a factor
for increased transmission
A number of avian species are highly
susceptible to WNV infection, exhibiting high
Figure 3. Maximum likelihood phylogenetic tree of 21 complete genomes of WNV. Viruses are grouped
accordingtofourdescribedlineagesofWNV(excludingthelineage5Indiangroup)andthegeneticresidueat
each NS3-249 site is indicated. The three independent emergences of the NS3-249P genotype has been
denoted on the tree. In each case an NS3-249Pro genotype emerged (designated in bold black) from a
predecessor genotype (Thr; designated in grey). The asterisks represent nodes with bootstrap support values
> 95%.
Vet. Res. (2009) 40:43 A.C. Brault
Page 8 of 19 (page number not for citation purpose)viremias and associated mortality rates, and
decreases in abundance [88]. Although it could
be concluded that this resultant reduction of the
breeding population would diminish transmis-
sion, high avian mortality is postulated to
potentially increase transmission in three ways:
(i) survival of previously infected and now
immune birds could dilute the effect of subse-
quent transmission events [50], (ii) mortality
in birds is associated with high peripheral vire-
mia leading to the efﬁcient infection of moder-
ately susceptible mosquito vectors [23, 77, 83],
and (iii) increased pathological manifestations
could favor increased infection of mosquitoes
due to reduced anti-mosquito defensive behav-
ior of moribund avian hosts [33] as well as
increased attractiveness to mosquitoes as a
result of hyperthermia [77]. The time period
inwhichavianhostssuchasAMCRarethemost
viremic coincides with maximal viremia and
moribund birds, presenting with elevated vire-
mias on the ground could result in increased
efﬁciency for infectivity of contact with vector
mosquitoes, thereby increasing transmission
potential of WNV to humans or equines [108].
Furthermore, it has been hypothesized that vec-
tor-borne agents have the potential for tolerance
ofhigher levels of mortality. Thishasbeentheo-
rizedtoresultfromtheneedfordisseminatedrep-
licationfortheinfectionofarthropodvectorsthat
often results in more serious clinical manifesta-
tionswithinthevertebratehost.Thetransmission
of vector-borne viruses by mobile vectors has
also been postulated to compensate for any
dampening of transmission due to the lack of
mobility of moribund vertebrate hosts [34, 43].
In contrast to WNV transmission in North
America in which low oral infection rates of
Culex spp. vectors are likely offset by high vire-
mias in avian hosts, limited avian mortality and
low oral infection thresholds of Cx. univittatus
and Cx. tritaeniorhynchus vectors are transmis-
sion hallmarks within endemic foci. Although a
few studies have demonstrated geographic dif-
ferences in susceptibility of Old World endemic
mosquito populations [2, 56], vector compe-
tence experiments with North American mos-
quitoes have indicated considerable temporal
and spatial variability for oral susceptibility
with no discernable pattern that could be linked
to ampliﬁcation [125]. These data taken
together indicate the importance of avian ampli-
ﬁcation by invasive WNV for infection of mar-
ginally susceptible North American Culex spp.
while low oral infection thresholds of speciﬁc
vectors can allow for transmission in the
absence of high avian viremias within endemic
transmission. These differing evolutionary strat-
egies are also evident with a closely related
ﬂavivirus, SLEV. Comparatively, despite the
fact that they utilize the same avian hosts and
mosquito vectors, SLEV has an approximately
10-fold greater oral susceptibility than WNV
but produces low magnitude viremias and is
less virulent in birds [122].
2.1.4. Viral adaptation for replication
at higher temperature
One factor that has classically deﬁned the
limit of the host range utilized by an RNAvirus
has been its ability to replicate at elevated tem-
perature [36, 61]. Arboviruses such as WNV
have a wide range of temperatures in which
they must replicate in order to be propagated
within both vertebrate and invertebrate hosts.
An arbovirus such as dengue that replicates in
primates is incapable of replicating at tempera-
tures above 39 C .T h i sc o u l db ea ni m p o r t a n t
factor in the inability of these viruses to utilize
birds (that have higher body temperatures) as
vertebrate hosts [85]. Much of our knowledge
in reference to replication at alternative temper-
atures is the result of the generation of temper-
ature sensitive (ts) viral mutants for the
identiﬁcation of the functional role of viral pro-
teins in the replication process [140] or the
development of mutants that have impaired rep-
lication capacity [20, 167] for the development
of vaccines. Replication of arboviruses in a two
host system can moderate the amount of selec-
tion that can take place in either the vertebrate
or invertebrate host [159]. Evidence also sug-
gests that in vitro selection for increased repli-
cation in vertebrates can result in a decreased
ability to replicate in mosquito tissues [54].
The temperature spectrum for which different
arboviruses can replicate (and subsequently
the hosts that they are capable of utilizing) is
poorly understood.
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importance of both temperature constraints
within avian hosts [77] as well as mosquito vec-
tors for WNV transmission. Degree-day models
have identiﬁed the replication limit of WNV in
mosquito vector to be constrained by tempera-
tures below 14 C and further demonstrated
that the strain of WNV introduced to North
American requires warmer temperatures for dis-
semination and subsequent transmission [124]
than a WNV strains from sub-Saharan Africa
[31]. Further data has demonstrated that the
genotype of WNV that has predominated in
North America since 2002, the WN02 geno-
type, seems to disseminate more rapidly and
at a more efﬁcient level at elevated temperatures
than the prototype NY99 North American strain
[75, 103]. This shortening of the extrinsic incu-
bation period (EIP), the time between a mos-
quito imbibing an infectious bloodmeal and
being capable of transmitting virus by bite,
could have been the factor by which this geno-
type of virus has been selected. Analyses of
temperature patterns in the USA have demon-
strated an association between above-normal
temperatures and epidemics of WNV in north-
ern latitudes [124]. These data coupled with
the ﬁnding of increased efﬁciency of vector dis-
semination at elevated temperatures of the pre-
dominant WNV genotype indicate temperature
as a potential important selection criterion for
WNV evolution.
2.2. Environmental factors associated
with emergence
2.2.1. Climate perturbation
Climate change can have a direct effect on
WNV ampliﬁcation rates in poikilothermic
mosquito vectors as external temperature has
been documented to have an inverse relation-
ship to the duration of the EIP [124]. Addition-
ally, increases in transmission season can result
as well as expansion of transmission to more
extreme latitudes and elevations. Although
increasing temperature is negatively correlated
with longevity of mosquitoes, in most instances
the increased dissemination and transmission
rates actually result in increased transmission
efﬁciency. Patterns of WNV transmission are
signiﬁcantly linked to the abundance of vector
populations. It has been determined that heavy
rainfall in the spring and warm, dry tempera-
tures during the summer are optimal for Culex
spp. population increases and are positively cor-
related with WNV transmission [120, 126, 137,
138].
2.2.2. Species diversity, species behavior
and transmission dynamics
One explanation for the lack of WNV-
associated disease in Latin America is the
increased avian species diversity in the tropics.
It is hypothesized that increased species diver-
sity could negatively impact transmission of
WNV if there was a high proportion of incom-
petent hosts. One study has made such a con-
nection by identifying a negative correlation
between non-passerine species diversity and
the force of WNV transmission, presumably
owing to a dilution effect of vertebrate hosts
with incompetent non-passerine avian species
[44]. Other studies have suggested the impor-
tance of ‘‘super-spreaders’’ or certain avian spe-
cies such as the American robin (Turdus
migratorius) in temperate habitats that appear
to not only be highly susceptible to infection
with WNV but also are preferential sources
for bloodmeals [73]. These concepts will
require further investigation as a number of
competing theories for the reduced impact of
WNV in Latin America have been proposed
including the circulation of WNV strains with
reduced virulence phenotypes [15] and the
potential inhibitory role of acquired immunity
to heterologous ﬂavivirus circulation in
Mexico, Central and South America [47].
Shifts in mosquito host selection have been
documented and associated with the potential
for increased infection. One study indicated that
Culex pipiens mosquitoes in the northeastern
USA shift their feeding behavior from highly
competent American robins to mammals and
humans in the late summer to early fall, coin-
ciding with the emigration of this avian species
[74]. This host switching has also been
observed with Culex tarsalis in the western
USA [150] and Cx. nigripalpus in Florida
Vet. Res. (2009) 40:43 A.C. Brault
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behavior in the tangential transmission of
WNV. Utilizing microsatellite markers to genet-
ically distinguish Nearctic and Palearctic Culex
spp. mosquitoes, one study inferred that
Palearctic European species limit their feeding
to avian hosts while North American Nearctic
species feed indiscriminately upon avian and
mammalian hosts [49] and concluded that this
differential feeding behavior was the explana-
tion for the lack of persistent WNV activity in
Europe. However, a number of other studies
[144] have provided evidence that Palearctic
European Culex spp. feed on both mammalian
and avian hosts, which contradicts the conclu-
sion that feeding behavior could modulate epi-
demiological patterns.
Previously, WNV infection in AMCR has
been uniformly lethal. However, the detection
of seropositive AMCR has been reported, indi-
cating that survival of individual birds in these
highly susceptible avian species can occur
[163]. Resistance to lethal infection could be
associated with lower peak viremia, thus lead-
ing to selection for WNV genotypes with
reduced oral infective thresholds for mosqui-
toes. As such, the effect that these modulations
in vertebrate host population susceptibility
could have on a concomitant selection for
increased oral susceptibility of mosquito vectors
should be monitored closely.
2.2.3. Role of heterologous ﬂaviviruses on WNV
transmission
The effect that the presence of heterologous
ﬂaviviruses has had on WNV transmission is a
subject of some debate; however, it is apparent
that increased avian herd immunity and mortal-
ity has had a detrimental effect on the transmis-
sion of, for instance, SLEV in southwestern
transmission foci [127]. Cross-protection with
WNV has been demonstrated to preclude
House ﬁnches (HOFI) from mounting detect-
able viremia following SLEV challenge. Con-
versely, inoculation of HOFI with SLEV prior
to WNV infection substantially reduces WNV
viremia to levels below that associated with oral
infection in most mosquito vectors [46, 123].
The potential effect of selective pressures from
heterologous ﬂaviviral immunity is currently
not known. Heterologous infection of vertebrate
hosts and mosquito vectors with alternative ﬂa-
viviruses could also result in potential recombi-
nation events as well as block mosquito
infectivity through barriers to super-infection.
Barriers to super-infection have been described
previously for arthropod-borne viruses [16, 32,
37, 41, 70, 141, 146]. For example, Aedes tri-
seriatus mosquitoes experimentally infected
with LaCrosse virus (LACV) have been shown
to be resistant to infection with another closely
related bunyavirus, Snowshoe Hare virus
(SSHV), approximately two days post-infection
[16]. A resistance period for dual infection was
identiﬁed for ticks co-infected with Thogoto
virus (THOV) for a period ranging between
24 h and 10 days of the initial infection with
an alternative THOV strain [32]. An Aedes alb-
opictus cell (C6/36) model further demonstrated
that the inhibition of the secondarily infecting
alphavirus is sequence speciﬁc. Alternative al-
phaviruses were blocked from super-infection
of C6/36 cells, while unrelated bunyavirus or
ﬂaviviruses could establish infection in alphavi-
ruses-infected C6/36 cells within the time per-
iod that these cells were resistant to infection
with heterologous alphaviruses [37, 70]. The
mechanism for this ‘‘super-infection exclusion’’
has not been identiﬁed; however, it has been
hypothesized that competitive exclusion
through template scavenging during RNA repli-
cation as well incompatible interactions
between viral proteins exclude replication of
the secondarily infecting virus. Inhibitory
effects on the super-infecting virus have been
identiﬁed in the processes of binding to the cel-
lular surface receptors, low pH fusion with the
endocytic vesicle, viral uncoating, viral replica-
tion as well as viral maturation and budding
[141].
2.2.4. Alternation of transmission patterns
Since WNV was introduced into the USA in
1999, an identiﬁed pattern has been recognized
in which the season of introduction is character-
ized by mild activity with few human cases.
This is followed by an epidemic year character-
ized by large numbers of cases, high infection
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conversions and mortality. The third season of
activity has been referred to as the ‘‘subsidence
year’’ in which human cases and enzootic indi-
cators drop precipitously, presumably owing to
increased herd immunity and avian depopula-
tion of highly competent ampliﬁcation hosts
[119]. Decreased avian herd immunity resulting
from the presence of naı ¨ve hatchlings as well as
waning immunity in after-hatch year birds is
then conducive for continued transmission dur-
ing subsequent seasons. In contrast, areas lack-
ing ‘‘super spreaders’’ or highly susceptible
corvids have failed to amplify enzootic trans-
mission to outbreak levels [127], whereas other
areas have experienced recurring epidemic level
transmission during sequential seasons [128].
The identiﬁcation of more severe neurological
syndromes in North America could be the result
of an increased virulence of the WNV strain
introduced as well as age-related exposure rates
in a completely naı ¨ve population. Within ende-
mic areas of WNV or SLEV transmission in
which youth exposure rates are high, neuroin-
vasive disease is uncommon. While the viru-
lence of the imported strains deserves further
attention, the role of a ‘‘virgin soil’’ effect
should not be overlooked as an explanation
for the altered disease phenotypes observed in
North America.
3. CONCLUSION
Since its introduction to North America,
WNV has undergone a dramatic increase in
geographic range and has demonstrated a
greater association with a more severe neuro-
logical clinical presentation. Undoubtedly a
number of ecological, virological and social
factors have contributed to this emergence.
Virological factors highlighted in this review
have included genetic adaptation for increased
replication in avian hosts as well as increased
dissemination in mosquito vectors at elevated
temperatures. As with other RNA viruses, the
presence of an error-prone polymerase that
lacks proofreading function coupled with the
large population sizes occurring in both infected
avian hosts and mosquito vectors allow for the
rapid selection of novel genotypes. Novel eco-
logical niches that have been created by cli-
matic perturbations and social or demographic
changes assuredly will result in the emergence
of novel genotypes to occupy these habitats
and thus perpetuate the continually changing
landscape of WNV epidemiology.
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